SCHEMBL318243

SCHEMBL318243

CC(C)(C)OC(=O)c1cc2ccccc2[nH]1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.63
LMNA P02545 3/20 0.63
TP53 P04637 1/20 0.63
L3MBTL1 Q9Y468 1/20 0.63
FLT3 P36888 5/20 0.59
MAPT P10636 2/20 0.57
HPGD P15428 2/20 0.57
DAO P14920 1/20 0.57
SRD5A2 P31213 1/20 0.57
HSD17B10 Q99714 1/20 0.57
PTPN2 P17706 2/20 0.55
PTPN1 P18031 2/20 0.55
ALDH1A1 P00352 2/20 0.51
GAA P10253 2/20 0.51
MAPK1 P28482 1/20 0.51
PDGFRB P09619 5/20 0.51
PDGFRA P16234 5/20 0.51
FGFR1 P11362 1/20 0.49
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29496122 1.00 KDM4E (0.63) KDM4ELMNATP53L3MBTL1FLT3
Ammonia Solution, Strong SCHEMBL27264748 0.98 KDM4E (0.61) KDM4ELMNATP53L3MBTL1FLT3
Benzoic Acid SCHEMBL28064485 0.92 KDM4E (0.56) KDM4ELMNATP53L3MBTL1FLT3
Pyridine SCHEMBL6315966 0.90 KDM4E (0.53) KDM4ELMNATP53L3MBTL1FLT3
SCHEMBL30881125 0.88 KDM4E (0.57) KDM4ELMNATP53L3MBTL1FLT3
SCHEMBL30382031 0.88 FLT3 (0.56) KDM4ELMNATP53L3MBTL1FLT3
SCHEMBL25192901 0.84 KDM4E (0.53) KDM4ELMNATP53L3MBTL1FLT3
SCHEMBL27538906 0.84 HRH4 (0.60) KDM4ELMNATP53L3MBTL1FLT3
SCHEMBL23000265 0.84 KDM4E (0.59) KDM4ELMNATP53L3MBTL1FLT3
SCHEMBL519591 0.81 KDM4E (0.69) KDM4ELMNATP53L3MBTL1FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101857594-A Tetrahydropyridoindole compounds, and preparation method and application thereof UNIV SOUTHERN MEDICAL 2010-10-13 CN claimed
CN-101124229-A Novel heterocyclic compounds for the treatment of inflammatory and allergic disorders GLENMARK PHARMACEUTICALS SA (CH) 2008-02-13 CN claimed
WO-2026103793-A1 TRICYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR, AND USE THEREOF 上海翰森生物医药科技有限公司 2026-05-21 WO disclosed
EP-3440097-B1 MACROCYCLIC INHIBITORS OF THE PD-1/PD-L1 AND CD80/PD-L1 PROTEIN/PROTEIN INTERACTIONS BRISTOL MYERS SQUIBB CO (US) 2024-10-23 EP disclosed
WO-2024051717-A1 COMPOUND AS PLK1 INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海深势唯思科技有限责任公司 2024-03-14 WO disclosed
CN-117642397-A Modified proteins and protein binders 上海睿跃生物科技有限公司 2024-03-01 CN disclosed
CN-117412959-A Substituted 1-aryl-1 '-heteroaryl compounds, substituted 1,1' -biaryl compounds, and methods of use thereof 爱彼特生物制药公司 2024-01-16 CN disclosed
EP-4265621-A1 PYRROLE DERIVATIVE, AND PREPARATION METHOD AND USE THEREFOR Shenzhen Sungening Bio-Medical Co., Ltd. (CN) 2023-10-25 EP disclosed
CN-111757882-B Compounds for treating, alleviating or preventing conditions associated with tau aggregates AC免疫有限公司 2023-08-22 CN disclosed
CN-116490069-A STAT degradation agent and application thereof 凯麦拉医疗公司 2023-07-25 CN disclosed
CN-114728917-A Oxamide derivative, preparation method and medical application thereof 深圳信立泰药业股份有限公司 2022-07-08 CN disclosed
EP-1250334-A2 AGENTS AND METHODS FOR THE TREATMENT OF PROLIFERATIVE DISEASES ELI LILLY AND COMPANY (US) 2002-10-23 EP disclosed
EP-1242420-A2 AGENTS AND METHODS FOR THE TREATMENT OF PROLIFERATIVE DISEASES ELI LILLY AND COMPANY (US) 2002-09-25 EP disclosed
CN-1370176-A Subsstituted heterocycle fused gamma-carbolines BRISTOL MYERS SQUIBB CO (US) 2002-09-18 CN disclosed
WO-2002010169-A1 PIPERAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2002-02-07 WO disclosed
WO-2001044235-A2 AGENTS AND METHODS FOR THE TREATMENT OF PROLIFERATIVE DISEASES ELI LILLY AND COMPANY (US) 2001-06-21 WO disclosed
WO-2001044247-A2 AGENTS AND METHODS FOR THE TREATMENT OF PROLIFERATIVE DISEASES ELI LILLY AND COMPANY (US) 2001-06-21 WO disclosed
EP-0411150-B1 INDOLE DERIVATIVES, PREPARATION THEREOF, AND DRUG FOR PREVENTING AND TREATING NEPHRITIS CONTAINING SAME OTSUKA PHARMA CO LTD (JP) 1996-11-27 EP disclosed
EP-0284174-B1 THERAPEUTIC PREPARATIONS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-07-29 EP disclosed
EP-0284174-A1 Therapeutic preparations IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1988-09-28 EP disclosed